Differentiating enhancing multiple sclerosis lesions, glioblastoma, and lymphoma with dynamic texture parameters analysis (DTPA): A feasibility study

Purpose: MR‐imaging hallmarks of glioblastoma (GB), cerebral lymphoma (CL), and demyelinating lesions are gadolinium (Gd) uptake due to blood–brain barrier disruption. Thus, initial diagnosis may be difficult based on conventional Gd‐enhanced MRI alone. Here, the added value of a dynamic texture parameter analysis (DTPA) in the differentiation between these three entities is examined. DTPA is an in‐house software tool that incorporates the analysis of quantitative texture parameters extracted from dynamic susceptibility contrast‐enhanced (DSCE) images. Methods: Twelve patients with multiple sclerosis (MS), 15 patients with GB, and five patients with CL were included. The image analysis method focuses on the DSCE image time series during bolus passage. Three time intervals were examined: inflow, outflow, and reperfusion time interval. Texture maps were computed. From the DSCE image series, mean, difference, standard deviation, and variance texture parameters were calculated and statistically analyzed and compared between the pathologies. Results: The texture parameters of the original DSCE image series for mean, standard deviation, and variance showed the most significant differences (P‐value between <0.00 and 0.05) between pathologies. Further, the texture parameters related to the standard deviation or variance (both associated with tissue heterogeneity) revealed the strongest discriminations between the pathologies. Conclusion: We conclude that dynamic perfusion texture parameters as assessed by the DTPA method allow discriminating MS, GB, and CL lesions during the first passage of contrast. DTPA used in combination with classification algorithms has the potential to find the most likely diagnosis given a postulated differential diagnosis.

[1]  S. Ng,et al.  Primary Cerebral Lymphoma and Glioblastoma Multiforme: Differences in Diffusion Characteristics Evaluated with Diffusion Tensor Imaging , 2008, American Journal of Neuroradiology.

[2]  M. Souweidane,et al.  Neuroendoscopic biopsy of brain lesions: accuracy and complications. , 2015, Journal of neurosurgery.

[3]  Dawit Assefa,et al.  Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation. , 2010, Medical physics.

[4]  J. Kesselring,et al.  Increased Endothelin-1 Plasma Levels in Patients With Multiple Sclerosis , 2001, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[5]  M. Cambron,et al.  Vascular aspects of multiple sclerosis , 2011, The Lancet Neurology.

[6]  G Johnson,et al.  Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. , 2007, AJNR. American journal of neuroradiology.

[7]  P. Marsden,et al.  Angiogenesis in glioblastoma. , 2013, The New England journal of medicine.

[8]  J. Foley,et al.  Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action , 2013, Biologics : targets & therapy.

[9]  M. Reni,et al.  Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  Sang Joon Park,et al.  Glioma: Application of Whole-Tumor Texture Analysis of Diffusion-Weighted Imaging for the Evaluation of Tumor Heterogeneity , 2014, PloS one.

[11]  T. Luider,et al.  Structural and expression differences between the vasculature of pilocytic astrocytomas and glioblastomas. , 2013, Journal of neuropathology and experimental neurology.

[12]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[13]  S. Heiland,et al.  Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging. , 2013, European journal of radiology.

[14]  J R Hesselink,et al.  Texture-Based Analysis of 100 MR Examinations of Head and Neck Tumors – Is It Possible to Discriminate Between Benign and Malignant Masses in a Multicenter Trial? , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[15]  Dakai Zhang,et al.  Use of texture analysis based on contrast‐enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma , 2016, Journal of magnetic resonance imaging : JMRI.

[16]  Theodoros N. Arvanitis,et al.  Texture analysis of T1- and T2-weighted MR images and use of probabilistic neural network to discriminate posterior fossa tumours in children , 2014, NMR in biomedicine.

[17]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[18]  Jullie W Pan,et al.  DEMONSTRATING THE PERIVASCULAR DISTRIBUTION OF MS LESIONS IN VIVO WITH 7-TESLA MRI , 2008, Neurology.

[19]  J. Slotboom,et al.  Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA) , 2013, PloS one.

[20]  E. Hattingen,et al.  Neuroradiological Viewpoint on the Diagnostics of Space-Occupying Brain Lesions , 2011, Clinical Neuroradiology.

[21]  Eun Sook Ko,et al.  Assessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis , 2016, Medicine.

[22]  L. Deangelis,et al.  Update on the management of primary CNS lymphoma. , 2000, Oncology.

[23]  G Johnson,et al.  Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2006, AJNR. American journal of neuroradiology.

[24]  Glyn Johnson,et al.  Comparison of region‐of‐interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas , 2007, Journal of magnetic resonance imaging : JMRI.

[25]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[26]  Theodoros N. Arvanitis,et al.  3D texture analysis of MR images to improve classification of paediatric brain tumours: a preliminary study , 2014, ICIMTH.

[27]  Nicolas Michoux,et al.  Texture Analysis of T2-Weighted MR Images to Assess Acute Inflammation in Brain MS Lesions , 2015, PloS one.

[28]  G. Schroth,et al.  A Novel Method for Analyzing DSCE-Images With an Application to Tumor Grading , 2008, Investigative radiology.

[29]  M. Manrique,et al.  Stereotactic biopsy for brain tumors: is it always necessary? , 2000, Surgical neurology.

[30]  Honglin Wan,et al.  Differentiating brain metastases from different pathological types of lung cancers using texture analysis of T1 postcontrast MR , 2016, Magnetic resonance in medicine.

[31]  Johan Trygg,et al.  ADC texture--an imaging biomarker for high-grade glioma? , 2014, Medical physics.

[32]  M. Convertino,et al.  Inferring Species Richness and Turnover by Statistical Multiresolution Texture Analysis of Satellite Imagery , 2012, PloS one.

[33]  C. Calli,et al.  Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. , 2006, European journal of radiology.

[34]  Peng Gong,et al.  Texture Analysis for Mapping Tamarix parviflora Using Aerial Photographs along the Cache Creek, California , 2006, Environmental monitoring and assessment.

[35]  Fang Liu,et al.  Prediction of hemorrhagic transformation in acute ischemic stroke using texture analysis of postcontrast T1‐weighted MR images , 2009, Journal of magnetic resonance imaging : JMRI.

[36]  H. Matsuda,et al.  Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy. , 2013, Internal medicine.

[37]  T. Jaspan,et al.  Metrics and Textural Features of MRI Diffusion to Improve Classification of Pediatric Posterior Fossa Tumors , 2014, American Journal of Neuroradiology.

[38]  E. Melhem,et al.  Advanced MR Imaging Techniques in the Evaluation of Nonenhancing Gliomas: Perfusion-Weighted Imaging Compared with Proton Magnetic Resonance Spectroscopy and Tumor Grade , 2013, The neuroradiology journal.

[39]  C. Good,et al.  Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade , 2012, Journal of Neuro-Oncology.

[40]  Andrzej Materka,et al.  Texture analysis methodologies for magnetic resonance imaging , 2004, Dialogues in clinical neuroscience.

[41]  Relationship between contrast enhancement on fluid‐attenuated inversion recovery MR sequences and signal intensity on T2‐weighted MR images: Visual evaluation of brain tumors , 2005, Journal of magnetic resonance imaging : JMRI.

[42]  M. Mrugala,et al.  Insights into the biology of primary central nervous system lymphoma , 2009, Current Oncology Reports.

[43]  B. Stieltjes,et al.  Funktionelle Bildgebung bei Hirntumoren (Perfusion, DTI, MR-Spektroskopie) , 2007, Der Radiologe.

[44]  M. Essig,et al.  [Functional imaging for brain tumors (perfusion, DTI and MR spectroscopy)]. , 2007, Der Radiologe.

[45]  E. Neuwelt,et al.  Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches. , 2006, Neurosurgical focus.

[46]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[47]  K Tsuchiya,et al.  Preliminary evaluation of fluid-attenuated inversion-recovery MR in the diagnosis of intracranial tumors. , 1996, AJNR. American journal of neuroradiology.

[48]  N. Otsu.  A threshold selection method from gray level histograms , 1979 .

[49]  Dafna Ben Bashat,et al.  Classification of tumor area using combined DCE and DSC MRI in patients with glioblastoma , 2014, Journal of Neuro-Oncology.

[50]  J. Slotboom,et al.  Characterization of Enhancing MS Lesions by Dynamic Texture Parameter Analysis of Dynamic Susceptibility Perfusion Imaging , 2016, BioMed research international.